Skip to main content

Atlas of Rheumatoid Arthritis

  • Book
  • © 2015

Overview

  • A high-quality educational initiative, written by leaders in the field of rheumatology, containing a collection of dozens relevant images, with extended descriptive captions and a comprehensive bibliography

  • Provides clinicians with a visual guide to rheumatoid arthritis, focusing on assessment, diagnosis, and treatment, including newer research into the signalling pathways involved in the pathogenesis of RA

  • Ideal for rheumatologists (both practitioners and trainees) involved in the treatment of patients with RA, including primary care physicians and nurses

  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 chapters)

  1. Rheumatoid Arthritis Overview

  2. Imaging of Rheumatoid Arthritis

  3. Treatment of Rheumatoid Arthritis

Keywords

About this book

Atlas of Rheumatoid Arthritis is a high-quality educational initiative, written by leaders in the field of rheumatology, containing a collection of approximately 150 relevant images, with extended descriptive captions and a comprehensive bibliography. The Atlas of Rheumatoid Arthritis will provide clinicians with a visual guide to rheumatoid arthritis, focusing on assessment, diagnosis and treatment, including newer research into the signalling pathways involved in the pathogenesis of RA, before focusing on the treatment of RA. Rheumatoid arthritis (RA) is the most common and most serious of the inflammatory arthritic disorders, and it dominates clinical rheumatological practice. Effective, early treatment is vital as this can slow the course of the disease and reduce joint damage. RA is usually treated using disease-modifying anti-rheumatic drugs (DMARDs), most commonly methotrexate. The newest treatments target the disease-causing immune elements specifically and directly.

Editors and Affiliations

  • University of Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom

    Paul Emery

About the editor

Professor Paul Emery is the Arthritis Research UK Professor of Rheumatology and Director of

the Leeds Institute of Rheumatic and Musculoskeletal Medicine and the Director of the Leeds

Musculoskeletal Biomedical Research Unit at Leeds Teaching Hospitals Trust in Leeds, United

Kingdom. Professor Emery was the President of the European League Against Rheumatism

(EULAR) from 2009–2011 and has served on the editorial boards major rheumatology journals

including Rheumatology, Arthritis and Rheumatism, Annals of the Rheumatic Diseases, Clinical

and Experimental Rheumatology, and Clinical Rheumatology. He was the inaugural President of

International Extremity MRI Society (ISEMIR) and is a National Institute for Health Research

(NIHR) Senior Investigator. Professor Emery is a recipient of the Roche Biennial Award for

Clinical Rheumatology; the Rheumatology Hospital Doctor of the Year Award; the EULAR

Prize for outstanding contribution to rheumatology research; and the Carol Nachman Prize

for outstanding rheumatology research. Professor Emery’s research interests center around the

immunopathogenesis and immunotherapy of rheumatoid arthritis, spondyloarthritis, and connective

tissue diseases. He has a special interest in the factors leading to persistent inflammation

and has published over 950 peer-reviewed articles in this area.

is the Arthritis Research UK Professor of Rheumatology and Director of

the Leeds Institute of Rheumatic and Musculoskeletal Medicine and the Director of the Leeds

Musculoskeletal Biomedical Research Unit at Leeds Teaching Hospitals Trust in Leeds, United

Kingdom. Professor Emery was the President of the European League Against Rheumatism

(EULAR) from 2009–2011 and has served on the editorial boards major rheumatology journals

including Rheumatology, Arthritis and Rheumatism, Annals of the Rheumatic Diseases, Clinical

and Experimental Rheumatology, and Clinical Rheumatology. He was the inaugural President of

International Extremity MRI Society (ISEMIR) and is a National Institute for Health Research

(NIHR) Senior Investigator. Professor Emery is a recipient of the Roche Biennial Award for

Clinical Rheumatology; the Rheumatology Hospital Doctor of the Year Award; the EULAR

Prize for outstanding contribution to rheumatology research; and the Carol Nachman Prize

for outstanding rheumatology research. Professor Emery’s research interests center around the

immunopathogenesis and immunotherapy of rheumatoid arthritis, spondyloarthritis, and connective

tissue diseases. He has a special interest in the factors leading to persistent inflammation

and has published over 950 peer-reviewed articles in this area.

Bibliographic Information

  • Book Title: Atlas of Rheumatoid Arthritis

  • Editors: Paul Emery

  • DOI: https://doi.org/10.1007/978-1-907673-91-7

  • Publisher: Springer Healthcare Tarporley

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Healthcare 2015

  • Softcover ISBN: 978-1-907673-90-0Published: 29 June 2015

  • eBook ISBN: 978-1-907673-91-7Published: 09 June 2015

  • Edition Number: 1

  • Number of Pages: XI, 264

  • Number of Illustrations: 51 b/w illustrations, 115 illustrations in colour

  • Topics: Rheumatology

Publish with us